Hypnobiome: A New Promising Frontier of Hypnotherapy in Functional Gastrointestinal Disorder (FGID)

Presented by Giuseppe De Benedittis, MD, PhD

Friday, April 11, 2025

9am-10:30am PT / 11am-12:30pm CT / 12pm-1:30pm ET

Event held online via Zoom, link to access provided upon registration.

Increasing evidence suggests that the gut-brain axis may play a key role in health and disease via a bidirectional communication network involving neural and immunoendocrine pathways. This complex interplay deeply influences both gut microbiota and brain behavior. Pathobiome or gut dysbiosis is relevant for the pathogenesis of functional gastrointestinal disorders, such as IBS, chronic pain syndromes, and neurological and mental disorders. As a consequence, targeting the gut microbiota is emerging as a novel, effective therapeutic perspective.

Among many treatment options, psychological interventions, including hypnosis, have been used to target the so-called psychobiome and its hypnotic analogue, i.e., hypnobiome, referring to their potential efficacy to modulate the mind-gut axis in IBS patients. Dr. De Benedittis will provide a narrative review of the recent literature and review circumstantial evidence suggesting that the hypnobiome represents a promising frontier for hypnotherapy.

Zoom link will be available on course page in “My Courses” upon event registration. 

This program, when attended in its entirety, offers 1.5 CEs for Psychologists, 1.5 IL CEUS for Counselors and Social Workers, or 1.5 BBS California CEUs for LPCCs, LPSW, and LMFTs.